Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     



This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Google Scholar
Right arrow Articles by Moreira, J. M.
Right arrow Articles by Gromova, I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreira, J. M.
Right arrow Articles by Gromova, I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on June 26, 2009
Revised on September 25, 2009
Accepted on September 25, 2009

Bladder cancer associated protein: a potential prognostic biomarker in human bladder cancer

Jose M. Moreira, Gita Ohlsson, Pavel Gromov, Ronald Simon, Guido Sauter, Julio E. Celis, and Irina Gromova

Proteomics in Cancer, Danish Cancer Society, Copenhagen Ø DK-2100

Corresponding Author: jom{at}cancer.dk

It is becoming increasingly clear that no single marker will have the sensitivity and specificity necessary to be used on its own for diagnosis/prognosis of tumors. Inter-patient and intra-tumor heterogeneity provide overwhelming odds against the existence of such an ideal marker. With this in mind our laboratory has been applying a long-term systematic approach to identify multiple biomarkers that can be used for clinical purposes. As a result of these studies, we have identified and reported several candidate biomarker proteins that are deregulated in bladder cancer. Following the conceptual biomarker development phases proposed by the Early Detection Research Network we have taken some of the most promising candidate proteins into post-discovery validation studies and here we report on the characterization of one such biomarker, the Bladder Cancer Associated Protein (BLCAP), formerly termed Bc10. In order to characterize BLCAP protein expression and cellular localization patterns in benign bladder urothelium and UCs we used two independent sets of samples from different patient cohorts; a reference set consisting of 120 bladder specimens (formalin-fixed as well as frozen biopsies), and a validation set consisting of 2108 retrospectively collected UCs with long-term clinical followup. We could categorize the UCs examined into four groups based on levels of expression and sub-cellular localization of BLCAP protein, and showed that loss of BLCAP expression is associated with tumor progression. The results indicated that increased expression of this protein confers an adverse patient outcome, suggesting that categorization of staining patterns for this protein may have prognostic value. Finally, we applied a combinatorial two-marker discriminator using BLCAP and A-FABP, another UC biomarker previously reported by us, and found that the combination of the two markers correlated more closely with grade and/or stage of disease than the individual markers. The implications of these results in biomarker discovery are discussed.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement